Antisense Technology
Preclinical Study Data Reported for Oncogene Inhibitor
Published in Gene Therapy Weekly, October 19th, 2000
The studies, which the company believes will form the basis of an Investigative New Drug filing and commencement of a Phase Ib/II cancer study around year end, were part of data presented at the seventh annual CaP CURE prostate cancer scientific retreat held in September 2000.
Patrick Iversen, PhD, AVI, presented data on AVI's clinical development of Oncomyc-NG, a NeuGene antisense therapy that has completed preclinical studies and Phase I clinical trials. The compound targets the oncogene...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2000-10-19)
More Articles from Gene Therapy Weekly
- HIV Gene Therapy
Antisense Enables Long-Term Survival of Transduced Immune Cells - Pancreatic Cancer
Sm-Like Oncogene is Novel Target for Gene Therapy - Animal Models
Immortomouse Hepatocytes Useful for Hepatic Gene Therapy Model - Bladder Cancer
p53 Gene Transfer Chemosensitizes Tumor in vivo - Cancer Gene Therapy
Scientists to Try Altering Gene Carrier to Improve its Ability to Bind to Cancer Cells - Lysosomal Storage Diseases
Intrahepatic Gene Therapy is Corrective in Murine Model - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
